疾病负担和治疗模式在美国患者中Hidradenitis Suppurativa:一个回顾性队列研究
Amit Garg1, Yvonne Geissbühler2, Emma Houchen3
1Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, 11042, USA. amgarg@Northwell.edu.
American journal of clinical dermatology
|June 28, 2023
概括
补腺炎 (HS) 患者在诊断后出现越来越多的并发症和高医疗费用. 综合,多学科的护理对于管理这种慢性皮肤疾病至关重要.
科学领域:
- 皮肤病学 皮肤病学
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
背景情况:
- 补腺炎 (HS) 是一种慢性,自发炎性皮肤疾病,具有显著的并发症.
- 阿达利穆马布是目前批准用于HS治疗的唯一生物药物.
- 了解HS患者的特征和医疗保健利用是生物批准后至关重要的.
研究的目的:
- 评估HS患者的社会人口统计因素,并发症,治疗模式和医疗资源利用率 (HCRU).
- 评估与成人和青少年群体中HS相关的经济负担.
- 为HS患者制定综合护理策略提供信息.
主要方法:
- 美国成年和青少年HS患者的回顾性队列研究.
- 数据来源于Optum的Clinformatics®数据商城数据库 (2016年1月至2018年12月).
- 分析包括患者人口统计,并发症,治疗,HCRU和2年后指数期的成本.
主要成果:
- 确定了超过10,900例HS患者;诸如高血压,肥胖和糖尿病等并发症普遍存在.
- 伴随性疾病负担在诊断后增加;与HS相关的手术不常见.
- 抗生素是常见的治疗方法;生物使用率很低 (3.5%的成年人,1.8%的青少年).
- 两年的医疗费用总额相当高:成年人为42,143美元,青少年为16,057美元.
结论:
- 随着时间的推移,HS患者的并发症负担和医疗费用逐渐增加.
- 高的全因和HS特异性HCRU和成本强调了疾病的影响.
- 研究结果强调,需要采用多学科的方法来照顾HS患者.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
303
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
303
01:17Chronic Bowel Disorders: Introduction
490
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
490
01:22Healthcare Associated Infections II: Preventive Measures
2.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
226
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
226
01:17Drugs for Treatment of Diarrhea-Predominant IBS
218
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
218
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
199
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
199